Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1361-1379

  Palmer, Matthew R ^a,c   Goorley, J Timothy ^a,b   Kiger III, W S ^a,b   Busse, Paul M ^a   Riley, Kent J ^b   Harling, Otto K ^b   Zamenhof, Robert G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Boron neutron capture therapy (BNCT); Boronophenylalanine fructose (BPA f); Clinical trial; Glioblastoma multiforme (GBM); Metastatic melanoma; Radiotherapy; Treatment planning

Indexed keywords

BRAIN; DOSIMETRY; FRUCTOSE; IRRADIATION; NEUTRONS; TISSUE; TUMORS;

NEUTRON CAPTURE THERAPY;

RADIATION;

4 BORONOPHENYLALANINE; FRUCTOSE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MELANOMA; MONTE CARLO METHOD; NEUTRON CAPTURE THERAPY; PATIENT POSITIONING; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RELATIVE BIOLOGIC EFFECTIVENESS; TREATMENT PLANNING;

ADULT; AGED; BORON; BRAIN; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEUTRON CAPTURE THERAPY; NEUTRONS; PHANTOMS, IMAGING; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036680149     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02862-6     Document Type: Article

References (77)

1. Boron neutron capture therapy
2. The radiation biology of boron neutron capture therapy
3. The chemistry of neutron capture therapy
4. Boron neutron capture therapy of brain tumors: Past history, current status, and future potential
5. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
6. Biological effects and therapeutic possibilities of neutrons
7. Radiobiology of a particles III. Cell inactivation by α-particle traversals of the cell nucleus
8. Radiation risk to low fluences of α particles may be greater than we thought
9. The possible use of neutron capture isotopes such as boron-10 in the treatment of neoplasms I. Intracranial tumors
10. Neutron capture therapy with boron in the treatment of glioblastoma multiforme
11. Early history of development of boron neutron capture therapy for tumors
12. A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit
13. Correlation of drug penetration of brain and chemical structure
14. Evaluation of boron-compounds for use in neutron capture therapy of brain tumors. I. Animal investigations
15. Studies on neutron capture therapy
16. Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation
17. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
18. Selective thermal neutron capture therapy and diagnosis of malignant melanoma: From basic studies to first clinical treatment
19. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: A cautionary note
20. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex
21. Neutron beams for neutron capture therapy at the MIT Research Reactor
22. On-line beam monitoring for neutron capture therapy at the MIT Research Reactor
23. The requirements and development of neutron beams for neutron capture therapy of brain cancer
24. Sensitivity studies of beam directionality, beam size and neutron spectrum for a fission converter-based epithermal neutron beam for boron neutron capture therapy
25. The fission converter based epithermal neutron irradiation facility at the MIT reactor
26. Determination of boron biological tissues by inductively coupled plasma automic emission spectrometry
27. An improved prompt gamma neutron activation analysis facility using a focused diffracted neutron beam
28. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy
29. Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy
30. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data
31. Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor
32. Clinical follow-up of patients with melanoma of the extremity treated in a Phase I boron neutron capture therapy protocol
33. A Phase I/II trial of boron neutron capture therapy (BNCT) for glioblastoma multiforme using intravenous boronophenylalanine-fructose complex and epithermal neutrons: Early clinical results
34. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons
35. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory
36. Boron neutron capture therapy for glioblastoma multiforme: Interim results from the Phase I/II dose-escalation studies
37. The Harvard-MIT BNCT program: Overview of the clinical trials and translational research
38. Status report on the European clinical trial of BNCT at Petten (EORTC protocol 11961)
39. Neutron-capture therapy of brain tumours: Neutron sources, neutron-capture drugs, biological tests and clinical perspectives in the Czech Republic
40. The BNCT Project in the Czech Republic
41. First clinical results on the Finnish study on BPA-mediated BNCT in glioblastoma
42. The Swedish facility for boron neutron capture therapy
43. Accelerator-based epithermal neutron beam design for neutron capture therapy
44. Development of a high-power water cooled beryllium target for use in accelerator-based boron neutron capture therapy
45. Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors
46. Explanation of cerebral white-grey contrast in computed tomography
47. Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models
48. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity
49. Biodistribution of p-boronophenylalanine (BPA) in patients with glioblastoma multiforme for use in boron neutron capture therapy
50. 10B in blood after boronophenylalanine-fructose administration in humans
51. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma
52. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro
53. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning
54. Response of the central nervous system to boron neutron capture irradiation: Evaluation using rat spinal cord model
55. Comparative assessment of single-dose and fractionated boron neutron capture therapy
56. Physical and biological basis of radiation therapy
57. Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation
58. The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapy
59. Response of glioblastoma cell lines to low dose rate irradiation
60. Microdosimetry studies at the Harvard/MIT Phase-I clinical trial of boron neutron capture therapy
61. Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo
62. Neutron capture therapy beams at the MIT research reactor
63. Head phantoms for neutron capture therapy
64. Estimates for absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom
65. NIH Image: A public domain image processing program for the MacIntosh
66. MacNCTPlan: An improved Macintosh based BNCT treatment planning program
67. Monte Carlo techniques should replace analytical methods for estimating dose distributions in radiotherapy treatment planning
68. The impact of electron transport on the accuracy of computed dose
69. Monte Carlo simulation of the MIT research reactor
70. MCNP speed advances in BNCT
71. MCNP enhancements, parallel computing, and error analysis for BNCT
72. Neutronic design of a fission converter-based epithermal neutron beam for neutron capture therapy